Results will be presented at the 66th American Society of Hematology Annual Meeting PHILADELPHIA, Dec. 7, 2024 /PRNewswire/ — Researchers at Children’s Hospital of Philadelphia (CHOP) and the Children’s Oncology Group (COG) announced the results of a Phase 3 study that demonstrated…

Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival of 96% THOUSAND OAKS, Calif., Dec. 7, 2024 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new data demonstrating that adding BLINCYTO® (blinatumomab) to chemotherapy significantly improves disease-free survival…

The findings will be presented during a scientific session at the American Society of Hematology Annual Meeting on Dec. 8 SEATTLE, Dec. 7, 2024 /PRNewswire/ — New findings set to be presented by Seattle Children’s Research Institute at the American Society of Hematology (ASH) Annual…

NEW YORK, Dec. 7, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”), of the important…

SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in DMC Global Inc. (NASDAQ: BOOM) shares Investors who purchased more than $100,000 in shares of DMC Global Inc. (NASDAQ: BOOM) between May and November 2024…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.